SGLT2 Inhibitors Reduce Proteinuria in Patients with IgA Nephropathy
Patients with IgA nephropathy experienced nearly 30% proteinuria reduction after 6 months of treatment with SGLT2 inhibitors.
Yaping Dong University First Hospital National Kidney Foundation Peking University First Hospital Peking University First From April
Source: hcplive.com